LexaGene: Automated, Rapid Pathogen Detection

October 27, 2020

MiQLab automated pathogen detection system

LexaGene is a molecular diagnostics company. In fact, they're developing a fully automated, rapid pathogen detection system for use at the point-of-need where samples are collected. Further, the system offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.

More on MiQLab

LexaGene’s MiQLab™ system aims to transform pathogen detection in multi-billion-dollar-markets.

MiQLab brings reference laboratory quality data to the point-of-need where samples are collected—to quickly detect multiple pathogens at once with sensitivity and specificity—and return results in ~1 hour. MiQLab is an automated, multiplexing PCR-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical answers in less time.

For more information on LexaGene Holdings, Inc., (TSX.V: LXG, OTCQB: LXXGF) please fill out the form below.

You might also like

Healthcare
Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology

Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

Healthcare
Investor Alert - Defence Therapeutics: Developing Immune-related Therapies for Cancer Treatment

Defence Therapeutics is a Canadian biotech company developing immune-related therapies for cancer treatment, including cancer vaccines, antibodies, and drug delivery vehicles.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, YouTube and more!